Sinuchron

Manufacturer
Energique, Inc. | Apotheca Company
Effective date
2022-03-17
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 22:05:54

Label at a glance#

ProductSinuchron HP
Active ingredientARSENIC TRIOXIDE, CALCIUM SULFIDE, GOLDENSEAL, POTASSIUM DICHROMATE, LYCOPODIUM CLAVATUM SPORE, MERCURIUS SOLUBILIS, SODIUM CHLORIDE, PHOSPHORUS, ANEMONE PRATENSIS, SEPIA OFFICINALIS JUICE, THUJA OCCIDENTALIS LEAFY TWIG
Label structure9 sections

Dosage and administration

Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS:

OTC - ACTIVE INGREDIENT SECTION

(in each drop): 9.09% of Arsenicum Album 30X, Hepar Sulphuris Calcareum 30X, Hydrastis Canadensis 30X, Kali Bichromicum 30X, Lycopodium Clavatum, Mercurius Solubilis 30X, Natrum Muriaticum 30X, Phosphorus 30X, Pulsatilla (Pratensis) 30X, Sepia 30X, Thuja Occidentalis 30X.

INDICATIONS:

OTC - PURPOSE SECTION

May temporarily relieve symptoms associated with chronic sinus issues such as painful pressure and thick nasal discharge.**

**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

WARNINGS:

WARNINGS SECTION

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.

KEEP OUT OF REACH OF CHILDREN.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.

INDICATIONS:

INDICATIONS & USAGE SECTION

May temporarily relieve symptoms associated with chronic sinus issues such as painful pressure and thick nasal discharge.**

**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

INACTIVE INGREDIENTS:

INACTIVE INGREDIENT SECTION

Demineralized water, 20% Ethanol.

QUESTIONS:

OTC - QUESTIONS SECTION

Dist. by Energique, Inc.

201 Apple Blvd

Woodbine, IA 51579   800-869-8078

PACKAGE LABEL DISPLAY:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ENERGIQUE

since 1987

HOMEOPATHIC REMEDY

SINUCHRON HP

1 fl. oz. (30 ml)

Sinuchron HPSinuchron HP

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
44911-0525-12022-03-17C16284748780-1d6a99b39-ee4f-a426-e053-dadaa90af4c2Drug Facts
44911-0525-12022-01-28C16284748780-1d6a99b39-ee4f-a426-e053-dadaa90af4c2Drug Facts

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
44911-052544911-0525-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ecdef486-9d14-4945-85da-de3bf8370ee6dfef35e1-21ac-492e-b642-33424771684e2022-03-17WarningsExact identifier
spl id: ecdef486-9d14-4945-85da-de3bf8370ee6
spl set id: dfef35e1-21ac-492e-b642-33424771684e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.